Tox

Similar documents
2

2

syoku10_10.indd

表紙/151708H

PowerPoint プレゼンテーション

(別添)安全性未審査の組換えDNA技術応用食品の検査方法_NIHS 最終版_YF

II

Perl + α. : DNA, mrna,,


エクセルカバー入稿用.indd


01_.g.r..

SC-85X2取説


<4D F736F F F696E74202D C835B B E B8CDD8AB B83685D>

QIAquick Spin プロトコールとトラブルシューティング ( /2008)

後期化学_01_濃度


困ったときのQ&A

Chromatin Immunoprecipitation (ChIP)

ii

はしがき・目次・事例目次・凡例.indd

Microsoft Word -

III


これわかWord2010_第1部_ indd

パワポカバー入稿用.indd

これでわかるAccess2010

i

1.WizardPlusSV日本語プロトコール

2

untitled

i

橡6.プログラム.doc

平成18年版 男女共同参画白書

パソコン機能ガイド

パソコン機能ガイド

Javaと.NET

2004年度日本経団連規制改革要望


高齢者の口蓋垂に生じた扁平上皮乳頭腫の1例

結婚生活を強める


2

™…



バイオ医薬品における特許の現状

活用ガイド (ハードウェア編)

活用ガイド (ソフトウェア編)



LA PCR™i n vitro Cloning Kit




東京都健康安全研究センター研究年報

遺伝子発現データの クラスタリングの理論的背景

活用ガイド (ソフトウェア編)

困ったときのQ&A

3 1 2

untitled

活用ガイド (ソフトウェア編)

TaKaRa PCR Human Papillomavirus Typing Set

『戦時経済体制の構想と展開』



ii

(報告書まとめ 2004/03/  )

Tox

2

ESD-巻頭言[ ].indd


長崎県地域防災計画

- 2 -


i


Wide Scanner TWAIN Source ユーザーズガイド

<4D F736F F D D838D B83588C9F8DB F4390B394C5816A8DB782B591D682A62E646F63>

I

untitled

MEGALABEL™


TaKaRa PCR Human Papillomavirus Detection Set

Step2 入門

1981 i ii ➀ ➁ 61

入門ガイド

Microsoft Word - 51プログラム名簿目次070913w.doc

Microsoft Word - ボツリヌス病原体検査マニュアル docx

DocuPrint CG 835 II 取扱説明書(サーバー編)

橡documents\TBD015J.PDF

別冊第5号出力(序~202頁).ren

01_SWGuide_V8.50.fm

Technical Bulletin TransFast TM Transfection Reagent E /

untitled

untitled

AllPrep DNA/RNA Micro プロトコールとトラブルシューティング ( /2008)

能書単頁9[1].5(2)

imageWARE Prepress Manager Select エディターガイド

Transcription:

Gel Shift Assay Systems No. TB110J 2000 9 E3050 E3300 I. 2 II. 2 III. A. 3 B. 3 IV. A. 4 B. 4 V. A. 5 B. HeLa Nuclear Extract DNA 6 C. AP2 Extract DNA 7 D. DNA- 7 VI. VII. VIII. IX. 8 8 9 13 X. A. 14 B. 14 C. 15 XI. 16 Tel. 03-3669-7980 prometec@jp.promega.com 1

I. (electrophoretic mobility shift)dna (1) DNA -DNA DNA( 2) ( ) 32 PDNA DNA DNA DNA DNA Gel Shift Assay Systems AP2(AP2 Extract)AP2 AP2 SP1 Consensus Oligo Gel Shift Binding 5 Buffer 20HeLa Nuclear Extract 52 (X.B 3) DNA II. Gel Shift Assay Core System E3050 20100 40µl HeLa Nuclear Extract 100u T4 Polynucleotide Kinase (PNK) 100µl T4 Polynucleotide Kinase 10X Buffer 200µl Gel Shift Binding 5X Buffer 20µl AP2 Extract 35pmol AP2 Consensus Oligo (1.75pmol/µl) 35pmol SP1 Consensus Oligo (1.75pmol/µl) 1 Protocol Gel Shift Assay System E3300 Gel Shift Assay Core System 35pmol AP1 Consensus Oligo (1.75pmol/µl) 35pmol OCT1 Consensus Oligo (1.75pmol/µl) 35pmol CREB Consensus Oligo (1.75pmol/µl) 35pmol NF- B Consensus Oligo (1.75pmol/µl) 35pmol TFIID Consensus Oligo (1.75pmol/µl) 1 Protocol : HeLa Nuclear Extract AP2 Extract -70-70-20 6 Tel. 03-3669-7980 prometec@jp.promega.com 2

III. (X.A) [ - 32 P]ATP (3,000Ci/mmol at 10mCi/ml) 0.5M EDTA TE 0.5M Na2HPO4 (ph 6.8) Whatman DE81 2.3cm circular filters Nuclease-Free Water (P1193) A. 1. Consensus Oligonucleotide (1.75pmol/µl) 2µl T4 Polynucleotide Kinase 10X Buffer 1µl [ - 32 P] ATP (3,000Ci/mmol at 10mCi/ml) 1µl Nuclease-Free Water 5µl T4 Polynucleotide Kinase (5 10u/µl) 1µl 10µl 2. 3710 3. 0.5M EDTA 1µl 4. 89µl TE IV : : 1:1 10µl2.2µl ATP B. 1. 1µl (III.A) 4Whatman DE81 2.3cm circular filters 2. 2 3. 250ml 0.5M Na2HPO4 (ph 6.8) 5 2 RI 4. 5. 6. = cpm 100 cpm 5'50%RI 30% 30% 10~100fmol5,000~20,000cpm Tel. 03-3669-7980 prometec@jp.promega.com 3

IV. (X.A) G-25 (5M 1M) 100% TE DNA (18mer) DNA A. TEG-25 (1) B. 1. 1/45MIII.A 4 2. 2 100% -70 C 1-20 3. 12,000 g 30 4. DNA 100µl 1M 5. 2 3 6. DNA100µl TE 1µl -20 Gel Shift Assay Tel. 03-3669-7980 prometec@jp.promega.com 4

V. DNA ( DNA)( ph ) (ph ) (2) (X.A) 4% ( 1 ) Nuclease-Free Water (P1193) gel loading 10 TBE 0.5 A. V.BV.C()Novex 6% DNA retardation 10 12cm 0.75mm 4% DNA- 1 (SDS) 1. (20ml) 4% 60:1 : TBE 10 1.0 ml 37.5:1 / (40%,w/v) 1.25 ml 40% (w/v) 0.75 ml 80% 625 µl dh2o 16.2 ml TEMED* 10 µl 10% APS** 150 µl *N,N,N N,-tetramethyl-ethylenediamine **ammonium persulfate (dh2o 10% in distilled water) : 60:1 40:1 (1) (1~2 ) Tel. 03-3669-7980 prometec@jp.promega.com 5

B. HeLa Nuclear Extract DNA SP1 HeLa Nuclear ExtractSP1 4 2 1. #1 ( ) 7µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 0µl HeLa Nuclear Extract 9µl #2 ( ) 5µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 2µl HeLa Nuclear Extract 9µl #3 ( ) 4µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 2µl HeLa Nuclear Extract 1µl (1.75pmol) ( SP1 Consensus Oligo) 9µl #4 ( ) 4µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 2µl HeLa Nuclear Extract 1µl (1.75pmol) ( AP2 Consensus Oligo) 9µl 2. 10 1µl 32 P SP1 Consensus Oligo 3. 20 : 4. 1µl gel loading 10 V.D : gel loading DNA gel loading Tel. 03-3669-7980 prometec@jp.promega.com 6

C. AP2 Extract DNA 4 2 1. #1 ( ) 7µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 0µl AP2 Extract 9µl #2 ( ) 6µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 1µl AP2 Extract 9µl #3 ( ) 5µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 1µl AP2 Extract 1µl (1.75pmol) ( AP2 Consensus Oligo) 9µl #4 ( ) 5µl Nuclease-Free Water 2µl Gel Shift Binding 5 Buffer 1µl AP2 Extract 1µl (1.75pmol) ( SP1 Consensus Oligo) 9µl 2. 10 1µl 32 P AP2 Consensus Oligo 3. 20 : 4. 1µl gel loading 10 D D. DNA- 1. 4%0.5 TBE 350V 10 Novex 6% DNA retardation 4% 0.5 TBE 350V 6% DNA retardation 0.5 TBE250~350V bromophenol blue 4320 30 2. Whatman 3MM filter paper -701X : AP2 SP1 Consensus Oligos DNA (2) Tel. 03-3669-7980 prometec@jp.promega.com 7

VI. 1. 2. 3. DNA 2HeLa 2. HeLa Nuclear Extracts AP1 ( ) 1 AP2 CREB 1 2 NF- B OCT1 SP1 TFIID * 1 1 2 1 1 2 TFIID * NF- B VII. V AP1: (c-jun) NF- B: 0.01mg/ml poly(di-dc) poly(di-dc) (3) ( AP2) poly(di-dc) poly(di-dc)dtt 5mM binding buffer c-jun in vitro DNA Gel Shift Binding 1 Buffer 1~2 fpu (footprinting units) (p49 p50) 10mM HEPES (ph 7.9) 50mM KCl 0.1mM EDTA 2.5mM DTT 10% glycerol 0.05% NP-40 0.28pmol NF- B Consensus Oligo 20µl 250 300ng25 C 30 gel loading -DNA Novex 6% TBE0.5% TBE300V 15 Tel. 03-3669-7980 prometec@jp.promega.com 8

VII. 1 2 5 10 20µg 100% DNA 1:1 5:1 Binding buffer 32 P DNA 2 DNA Zn Mg DNA- DNA DNA 4 TGE (1) gel loading bromophenol blue DNA loading poly(di-dc) poly(di-dc) DNA TFIIDpoly(dG-dC) poly(dg-dc) calf thymus DNA DNA -- (4) poly(di-dc) poly(di-dc) 0.1µg 2-3µg 50~100ng Tel. 03-3669-7980 prometec@jp.promega.com 9

DNA binding buffer DNA DNA DNA DNA DNA (AT) 4 binding buffer DNA (1) DNApoly(dI-dC) poly(di-dc) DNA DNA DNase Tel. 03-3669-7980 prometec@jp.promega.com 10

ammonium persulfate solution( 1 ) TBE 10~15V/cm DNA ( TBP)(30~35V/cm) ( NF- B ) Binding buffer DNA- Tel. 03-3669-7980 prometec@jp.promega.com 11

extract + AP2 oligo + cold AP2 oligo + AP2 oligo and noncompetitor 1. AP2 AP21 2 ( 32 PAP2) 3 32 PAP2 AP2( ) 4 32 PAP2 TFIID() DNAV Tel. 03-3669-7980 prometec@jp.promega.com 12

IX. 1. Ausubel, F.M. et al. (1989) In: Current Protocols in Molecular Biology, Vol. 2, John Wiley and Sons, New York. 2. Andersen, R.D. et al. (1990) Metal-dependent binding of a nuclear factor to the rat metallothionein-i promoter. Nucl. Acids Res. 18, 6049. 3. Lin, B. (1992) Gel shift analysis with human recombinant AP1 (c-jun): The effect of poly d(i-c) on specific complex formation. Promega Notes 37, 14. 4. Fried, M.G. and Crothers, D.M. (1984) Kinetics and mechanism in the reaction of gene regulatory proteins with DNA. J. Mol. Biol.172, 263. 5. Briggs, M.R. et al.(1986) Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234, 47. 6. Lee, W., Mitchell, P. and Tjian, R. (1987) Purified transcription factor AP-1 inter-acts with TPA-inducible enhancer elements. Cell 49, 741. 7. Williams, T. et al.(1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes and Development 2, 1557. 8. Lenardo, M.J. and Baltimore, D. (1989) NF-kappa B: a pleiotropic mediator of inducible and tissuespecific gene control. Cell 58, 227. 9. O Neill, E.A. et al. (1988) Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III. Science 241, 1210. 10. Roesler, W.J., Vandenbark, G.R. and Hanson, R.W. (1988) Cyclic AMP and the induction of eukaryotic gene transcription. J. Biol. Chem. 263, 9063. 11. Locker, J. and Buzard, G. (1990) A dictionary of transcription control sequences. J. DNA Sequencing and Mapping 1, 3. Tel. 03-3669-7980 prometec@jp.promega.com 13

X. A. gel loading 10X buffer 250mM Tris-HCl (ph 7.5) 0.2% bromophenol blue 40% glycerol Gel Shift Binding 5X Buffer 20% glycerol 5mM MgCl2 2.5mM EDTA 2.5mM DTT 250mM NaCl 50mM Tris-HCl (ph 7.5) 0.25mg/ml poly(di-dc) poly(di-dc) T4 Polynucleotide Kinase 10X Buffer 700mM Tris-HCl (ph 7.6) 100mM MgCl2 50mM DTT TBE 10X buffer (1L) 107.80g Tris base ~55g boric acid 7.44g disodium EDTA 2H2O 800ml boric acid ph ph boric acid 8.3 1 TE buffer 10mM Tris-HCl (ph 8.0) 1mM EDTA B. 3. ( ) SP1 (5) AP1 (c-jun) (6) AP2 (7) NF- B (8) OCT1 (9) 5 - ATT CGA TCG GGG CGG GGC GAG C -3 3 - TAA GCT AGC CCC GCC CCG CTC G -5 5 - CGC TTG ATG AGT CAG CCG GAA -3 3 - GCG AAC TAC TCA GTC GGC CTT -5 5 - GAT CGA ACT GAC CGC CCG CGG CCC GT -3 3 - CTA GCT TGA CTG GCG GGC GCC GGG C A -5 5 - AGT TGA GGG GAC TTT CCC AGG C -3 3 - TCA ACT CCC CTG AAA GGG TCC G -5 5 - TGT CGA ATG CAA ATC ACT AGA A -3 3 - ACA GCT TAC GTT TAG TGA TCT T -5 DNA 3 Zn O-glycosylated AP1 c-fos DNA TPA camp AP2 B B OCT 1 2 POU POU CREB (10) TFIID (11) 5 - AGA GAT TGC CTG ACG TCA GAG AGC TAG -3 3 - TCT CTA ACG GAC TGC AGT CTC TCG ATC -5 5 - GCA GAG CAT ATA AGG TGA GGT AGG A -3 3 - CGT CTC GTA TAT TCC ACT CCA TCC T -5 camp c-jun DNA TATA DNA TFIIDARNAII Tel. 03-3669-7980 prometec@jp.promega.com 14

C. Gel Shift Binding 5 Buffer 5 200µl E3581 Core Footprinting System 50 E3730 Nuclease-Free Water 50ml(2 25ml) P1193 rhap1 (c-jun) 50fpu E3061 rhnf- B (p49) 50gsu E3820 rhnf- B (p50) 50gsu E3770 fpu = footprint unit; gsu = gel shift unit. HeLaScribe Nuclear Extract, Gel Shift Assay Grade 3 40µl E3521 AP1 Oligonucleotide 175pmol E3201 35pmol E3202 AP2 Oligonucleotide 175pmol E3211 35pmol E3212 TFIID Oligonucleotide 175pmol E3221 35pmol E3222 SP1 Oligonucleotide 175pmol E3231 35pmol E3232 OCT1 Oligonucleotide 175pmol E3232 35pmol E3242 CREB Oligonucleotide 175pmol E3281 35pmol E3282 NF- B Oligonucleotide 175pmol E3291 35pmol E3292 Tel. 03-3669-7980 prometec@jp.promega.com 15

XI. Gel Shift Assay Systems: Gel Shift Assay System( IIIV) ( III.A) 1. Consensus Oligonucleotide (1.75pmol/µl) 2µl T4 Polynucleotide Kinase 10X Buffer 1µl [ - 32 P]ATP (3,000Ci/mmol at 10mCi/ml) 1µl Nuclease-Free Water 5µl T4 Polynucleotide Kinase (5 10u/µl) 1µl 10µl 2. 37 C 10 3. 1µl 0.5M EDTA 4. 89µl TE(IV) HeLa Nuclear Extract DNA (Section V.B) 1. SP1 2 4 #1 ( ) #2 ( ) 7µl Nuclease-Free Water 5µl Nuclease-Free Water 2µl Gel Shift Binding 5X Buffer 2µl Gel Shift Binding 5X Buffer 0µl HeLa Nuclear Extract 2µl HeLa Nuclear Extract 9µl 9µl #3 ( ) #4 ( ) 4µl Nuclease-Free Water 4µl Nuclease-Free Water 2µl Gel Shift Binding 5X Buffer 2µl Gel Shift Binding 5X Buffer 2µl HeLa Nuclear Extract 2µl HeLa Nuclear Extract 1µl 1µl (1.75pmol) (SP1 Consensus (1.75pmol) (AP2 Consensus Oligo) Oligo) 9µl 9µl 2. 10 1µl 32 PSP1 3. 20 4. 1µl gel loading 10X AP2 Extract AP2 Concensus Oligo AP2 Consensus Oligo 1µl AP2 Extract2µl HeLa Extract gel loading Tel. 03-3669-7980 prometec@jp.promega.com 16

XI. Gel Shift Assay Systems: ( V.D) 1. 4% TBE 350V 100.5X TBE 2. 350Vbromophenol blue 43 30 3. 70 X Tel. 03-3669-7980 prometec@jp.promega.com 17